Orthofix Medical Inc(OFIX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 4:00 PM ET (Korea 10/31 05:00)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -1.53 | Insider Own | 1.21% | Shs Outstand | 40.7M | Perf Week | -7.54% |
| Market Cap | 0.37B | Forward P/E | - | EPS next Y | 19.57% | Insider Trans | 59.9% | Shs Float | 40.2M | Perf Month | -1.52% |
| Enterprise Value | 0.53B | PEG | - | EPS next Q | -0.27 | Inst Own | 95.03% | Short Float | 5.94% | Perf Quarter | -26.02% |
| Income | -0.06B | P/S | 0.44 | EPS this Y | 49.57% | Inst Trans | 2.66% | Short Ratio | 6.3 | Perf Half Y | -23.85% |
| Sales | 0.83B | P/B | 0.86 | EPS next 5Y | 35% | ROA | -7.22% | Short Interest | 2.39M | Perf YTD | -40.17% |
| Book/sh | 10.54 | P/C | 3.54 | EPS past 3/5Y | -33.21% - | ROE | -13.91% | 52W High | -46.62% ($16.99) | Perf Year | -41.37% |
| Cash/sh | 2.56 | P/FCF | - | Sales past 3/5Y | 21.3% 15.13% | ROIC | -8.97% | 52W Low | 6.71% ($8.50) | Perf 3Y | -17.77% |
| Dividend Est. | - | EV/EBITDA | 31.74 | EPS Y/Y TTM | 51.77% | Gross Margin | 69.84% | Volatility(W/M) | 3.54% 3.62% | Perf 5Y | -74.79% |
| Dividend TTM | - | EV/Sales | 0.63 | Sales Y/Y TTM | 2.99% | Oper. Margin | -4.34% | ATR (14) | 0.44 | Perf 10Y | -76.29% |
| Dividend Ex-Date | - | Quick Ratio | 1.67 | EPS Q/Q | -8.33% | Profit Margin | -7.41% | RSI (14) | 42.3 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.84 | Sales Q/Q | 3.85% | SMA20 | -4.96% ($9.54) | Beta | 0.66 | Target Price | $13 |
| Payout | - | Debt/Eq | 0.61 | Earnings | 2026/11/9 | SMA50 | -3.37% ($9.39) | Rel Volume | 1.73 | Prev Close | $10.24 |
| Employees | 1605 | LT Debt/Eq | 0.6 | EPS/Sales Surpr. | 4.85% 0.79% | SMA200 | -18.27% ($11.1) | Avg Volume(3M) | 0.38M | Price | $9.07 |
| IPO | 1992/4/24 | Option/Short | Yes/Yes | Trades | 6331 | Volume | 657,870 | Change | -11.43% |
A U.S. orthopedic medical device company focused on spinal and limb reconstruction and bone growth stimulation. It supplies spinal implants, biologics, bone growth stimulation devices, and limb reconstruction solutions, and has established a leading position in the U.S. bone growth stimulation market as a small- to mid-cap medical device specialist.
Over the past 1 year, on the lower side
47% below its 1-year high.
Traded more than usual. That is 173% of its average volume.
Next earnings report: November 9
9 days to go.
OFIX has a sound balance sheet but weak earning power
Of every $100 in sales, $4.34 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +49.6% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $44. Peers typically go for $326.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -74.8%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 95.0%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #65 of 142 in the industry
Based on market cap of $369M.
RCEL#64 AVITA Medical Inc $389M PER - OFIX#65 Orthofix Medical Inc $369M PER - 
VMD#66 Viemed Healthcare Inc $368M PER 26.4 
CV#67 CapsoVision Inc $363M PER - 
MOBI#68 Mobia Medical Inc $352M PER - 
FAQ
What kind of company is OFIX?
OFIX belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of OFIX?
The market cap of OFIX is approximately $369M, ranking 3,402 within its sector.
What is the 52-week high and low for OFIX?
OFIX has recorded a 52-week high of $16.99 and a low of $8.50.
